Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement Of Cash Flows

v3.7.0.1
Condensed Statement Of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Cash Flows from Operating Activities:    
Net Loss $ (21,611,024) $ (4,149,042)
Adjustments to reconcile net loss to net cash used in operating activities:    
Compensatory stock 12,750 48,749
Depreciation and amortization 8,927 6,161
Amortization of premiums and discounts on marketable securities, net 5,773 13,308
Stock-based compensation 274,327 343,011
Amortization of deferred research and development arrangements (18,750) (18,750)
Unrealized loss (gain) on fair value of warrants 17,689,580 (855,955)
Financing expense   169,887
Amortization of deferred lease incentive (3,111) (3,111)
Deferred lease expenses (3,585) (2,601)
Changes in assets and liabilities:    
Prepaid expenses and other assets (356,608) 275,757
Accounts payable and accrued expenses (167,014) 622,969
Net Cash Used in Operating Activities (4,168,735) (3,549,617)
Cash Flows from Investing Activities:    
Purchase of equipment (3,965) (4,596)
Purchase of marketable securities (2,005,700) (1,721,760)
Redemption of marketable securities 2,720,000 960,000
Net Cash Provided by (Used in) Investing Activities 710,335 (766,356)
Cash Flows from Financing Activities:    
Issuance of common stock and units, net of issuance costs   4,580,187
Proceeds from exercise of stock warrants 2,366,106  
Net Cash Provided by Financing Activities 2,366,106 4,580,187
Net (Decrease) Increase in Cash and Cash Equivalents (1,092,294) 264,214
Cash and Cash Equivalents - beginning of period 11,578,473 10,199,440
Cash and Cash Equivalents - end of period 10,486,179 10,463,654
Non-cash financing and investing activties:    
Warrants issued   $ 2,575,860
Warrant liability extinguishment from exercise of warrants 3,029,115  
Stock subscription receivable from warrants exercised $ 30,000